A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells
Publication
, Journal Article
Zarif, JC; Hernandez, JR; Verdone, JE; Campbell, SP; Drake, CG; Pienta, KJ
Published in: Biotechniques
2016
Duke Scholars
Published In
Biotechniques
Publication Date
2016
Volume
61
Start / End Page
33 / 41
Publisher
Future Science Ltd London, UK
Related Subject Headings
- Bioinformatics
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Zarif, J. C., Hernandez, J. R., Verdone, J. E., Campbell, S. P., Drake, C. G., & Pienta, K. J. (2016). A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells. Biotechniques, 61, 33–41.
Zarif, Jelani C., James R. Hernandez, James E. Verdone, Scott P. Campbell, Charles G. Drake, and Kenneth J. Pienta. “A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells.” Biotechniques 61 (2016): 33–41.
Zarif JC, Hernandez JR, Verdone JE, Campbell SP, Drake CG, Pienta KJ. A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells. Biotechniques. 2016;61:33–41.
Zarif, Jelani C., et al. “A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells.” Biotechniques, vol. 61, Future Science Ltd London, UK, 2016, pp. 33–41.
Zarif JC, Hernandez JR, Verdone JE, Campbell SP, Drake CG, Pienta KJ. A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells. Biotechniques. Future Science Ltd London, UK; 2016;61:33–41.
Published In
Biotechniques
Publication Date
2016
Volume
61
Start / End Page
33 / 41
Publisher
Future Science Ltd London, UK
Related Subject Headings
- Bioinformatics
- 10 Technology
- 06 Biological Sciences